Brief: Hemcheck Sweden Has Received First Order From Narva Hospital In Estonia
March 1 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* HAS RECEIVED A FIRST ORDER FROM NARVA HOSPITAL IN ESTONIA
* ORDER IS OF LESS ECONOMIC VALUE BUT THERE IS POSSIBILITY
OF MORE
AND LARGER ORDERS FURTHER AHEAD
Source text for Eikon: ID:nWkrhdrVY
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln